Article By:
Terry Chrisomalis
Thursday, June 4, 2015 11:03 AM EDT
Opko Health Acquires Bio-Reference Laboratories to accelerate sales force for 4KscoreTM Test for prostate cancer. Shares of Opko are down 7% today while shares of Bio-Reference Laboratories are up 36% today on this deal.